What is the best approach to diagnose and manage recurrent urinary tract infections (UTIs) in nonpregnant adults, particularly postmenopausal women, in a Telehealth primary care setting?

Recurrent UTI Management in Nonpregnant Adults via Telehealth

Diagnostic Confirmation

Recurrent UTI requires culture-confirmed diagnosis and must be distinguished from asymptomatic bacteriuria, which should never be treated in nonpregnant adults. 1

Mandatory Diagnostic Criteria

• ≥2 symptomatic episodes within 6 months OR ≥3 episodes within 12 months 1, 2
• At least one episode must be confirmed by midstream urine culture showing ≥10⁵ CFU/mL of a single uropathogen 1, 3
• Obtain urine culture with each symptomatic episode before initiating antibiotics 2
• Asymptomatic bacteriuria (positive culture without symptoms) must not be treated, as this promotes antimicrobial resistance and provides no clinical benefit 1

Critical Telehealth Limitation

Telehealth cannot perform pelvic examination, assess post-void residual, or evaluate for prolapse—if diagnosis is uncertain, escalate to in-person assessment immediately. 1

---

Differential Diagnosis: When to Suspect Alternative Pathology

Red Flags Requiring Imaging or Specialist Referral

• Recurrent symptoms with negative cultures in a young woman strongly suggests urethral diverticulum (present in 30-50% of such cases) 4, 5
• Order pelvic MRI (not CT) as first-line imaging for suspected urethral diverticulum—MRI alters surgical management in 15% of patients 4, 5
• Relapsing infection with the same organism and susceptibility pattern (consider stones, abscess, foreign body) 1
• Second episode of pyelonephritis within 12 months (requires urinary tract imaging) 1
• Male recurrent UTI (requires urological evaluation for prostatic disease) 1

Do not perform routine cystoscopy or CT imaging for most women with recurrent cystitis unless relapsing infection is identified. 1, 2

---

Acute Episode Management

Treat each acute episode with narrow-spectrum, guideline-recommended antibiotics for standard duration—recurrent UTI does not justify broader-spectrum or longer courses. 1, 6

First-Line Antibiotic Options

• Nitrofurantoin 100 mg PO twice daily for 5 days 2, 6
• Fosfomycin trometamol 3 g PO single dose 2, 6
• Trimethoprim-sulfamethoxazole 160/800 mg PO twice daily for 3 days (only if local E. coli resistance <20%) 2, 6
• Trimethoprim 150 mg PO daily for 3 days 6

Avoid fluoroquinolones as first-line therapy due to antimicrobial stewardship concerns and increasing resistance rates. 2

---

Prevention Strategy: Hierarchical Approach

First-Line: Non-Antibiotic Interventions

1. Genitourinary Syndrome of Menopause (GSM) Assessment

GSM is the most under-recognized driver of recurrent UTI in postmenopausal women and must be screened for in all cases. 1

Screen all postmenopausal women for:

• Vaginal dryness or burning 1
• Dyspareunia 1
• Postcoital urinary symptoms 1
• Recurrent dysuria with negative cultures 1
• Poor response to antibiotics 1

Vaginal estrogen is the most effective non-antibiotic intervention, reducing UTI recurrence by up to 75%. 1

Prescribe vaginal estrogen:

• Estriol cream 0.5 mg vaginally nightly for 2 weeks, then twice weekly 1
• Minimum duration: 6-12 months, with review at 3-6 months 1
• Systemic estrogen is not required 1

2. Behavioral Modifications

• Increase fluid intake to 1.5 L/day in patients with low baseline intake 1, 2
• Void after sexual intercourse 2
• Avoid spermicide-containing contraceptives 2

3. Methenamine Hippurate

• 1 g PO twice daily, reviewed every 6 months 1, 6
• Effective non-antibiotic alternative to continuous antibiotic prophylaxis 1, 2

4. Cranberry Products

• May reduce recurrence in women <50 years; insufficient evidence in older adults 1, 2

5. Probiotics

• Benefits are strain-specific and inconsistent; not first-line therapy 1
• May be discussed as adjunct alongside vaginal estrogen, but document uncertain benefit 1
• Do not present as proven or definitive treatment 1

---

Patient-Initiated (Self-Start) Antibiotic Therapy

Patient-initiated therapy reduces overall antibiotic exposure compared with continuous prophylaxis and is safe when eligibility criteria are met. 1, 7

Eligibility Criteria (ALL must be met)

• Nonpregnant adult female 1
• ≥1 previous culture-confirmed UTI 1
• Clear ability to recognize symptoms 1, 7
• No systemic symptoms or red flags 1

Patient Instructions

• Commence antibiotics at symptom onset 1
• Seek medical review if symptoms do not improve within 48 hours 1

Women can accurately self-diagnose UTI with 84% accuracy when trained. 7

---

Antibiotic Prophylaxis (Last-Line Strategy)

Never prescribe prophylaxis for asymptomatic bacteriuria—this promotes antimicrobial resistance without clinical benefit. 1

Postcoital Prophylaxis

For intercourse-triggered UTIs (single dose within 2 hours of intercourse; max once daily): 1

• Nitrofurantoin 50 mg PO 1
• Trimethoprim 150 mg PO 1
• Cephalexin 250 mg PO 1

Continuous Prophylaxis

Reserved for patients who fail all other strategies. 1, 2

Options (nightly for 6 months, then stop and reassess): 1

• Trimethoprim 150 mg 1, 8
• Cephalexin 250 mg 1
• Nitrofurantoin 50 mg 1

Long-term nitrofurantoin requires monitoring for pulmonary, hepatic, and neurological toxicity. 1

Discuss risks before prescribing: candidiasis, antimicrobial resistance, C. difficile infection. 1

---

Male Recurrent UTI

Do not commence prophylaxis in males without specialist advice—male recurrent UTI often indicates prostatic pathology and requires urological evaluation. 1, 9

Telehealth role is coordination, not independent long-term management. 1

---

Escalation & Referral Triggers

Refer for in-person or specialist review if: 1

• Persistent symptoms with negative cultures 1
• Relapsing infections with same organism 1
• Recurrent pyelonephritis 1
• Failure of prophylaxis 1
• Diagnostic uncertainty 1
• Suspected obstruction or abscess 1

---

AHPRA-Defensible Documentation

Required documentation for every recurrent UTI case: 1

• Culture-confirmed diagnosis 1
• Explicit exclusion of asymptomatic bacteriuria 1
• Assessment for GSM and rationale for estrogen therapy 1
• Prevention strategies trialed 1
• Antibiotic risks discussed 1
• Review and stop dates 1
• Clear escalation and follow-up plan 1

Recurrent UTI management without addressing GSM or stewardship is indefensible in Telehealth. 1

---

Common Pitfalls to Avoid

• Do not treat asymptomatic bacteriuria—this is the most common error in recurrent UTI management 1
• Do not prescribe antibiotics for recurrent pyuria alone without symptoms 1
• Do not order CT urography instead of MRI for suspected urethral diverticulum 4, 5
• Do not perform extensive workup (cystoscopy, imaging) in women <40 years without risk factors 2
• Do not use fluoroquinolones as first-line therapy 2
• Do not prescribe continuous prophylaxis without first trialing vaginal estrogen in postmenopausal women 1